BZW2 promotes the malignant progression of colorectal cancer via activating the ERK/MAPK pathway
Authors:
- 23 October 2019
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 235 (5) , 4834-4842
Abstract
Colorectal cancer (CRC) is one of the most prevalent malignant solid cancers worldwide involving the dysregulation of multiple signaling molecules. However, the role and corresponding mechanism of basic leucine zipper and W2 domains 2 (BZW2) in CRC development, to our knowledge, has not been reported. We found BZW2 was overexpressed in human CRC tissues compared with that in paired adjacent colorectal samples. BZW2 overexpression was closely associated with tumor T stage (p = .030), metastatic lymph nodes (p = .037), TNM stage (p = .018) and the worse prognosis of CRC patients (p = .009). Moreover, BZW2 was an independent disadvantage prognostic factor (p = .031). BZW2 also showed an increased expression in different invasive CRC cell lines. Its silencing and overexpression diminished and increased cell proliferation, invasion, and migration in Colo205 and HCT116 cells via specifically activating of extracellular‐signal‐regulated kinase (ERK)/mitogen‐activated protein kinase (MAPK) signaling. Moreover, ERK/MAPK inhibitor PD98059 reverse the enhancement of cell proliferation, invasion, and migration in BZW2 overexpressing HCT116 cells. BZW2 silencing also inhibited subcutaneous tumors growth and p‐ERK expression in vivo. BZW2 promotes the malignant progression of CRC via activating ERK/MAPK signaling, which provided a promising gene target therapy for CRC.Keywords
This publication has 23 references indexed in Scilit:
- BZW2 gene knockdown induces cell growth inhibition, G1 arrest and apoptosis in muscle‐invasive bladder cancers: A microarray pathway analysisJournal of Cellular and Molecular Medicine, 2019
- Angiopoietin-like protein 1 inhibits epithelial to mesenchymal transition in colorectal cancer cells via suppress Slug expressionCytotechnology, 2019
- The role of STAG2 in bladder cancerPharmacological Research, 2018
- Systematic review of colorectal cancer screening guidelines for average-risk adults: Summarizing the current global recommendationsWorld Journal of Gastroenterology, 2018
- Downregulation of BZW2 inhibits osteosarcoma cell growth by inactivating the Akt/mTOR signaling pathwayOncology Reports, 2017
- Cohesin subunits, STAG1 and STAG2, and cohesin regulatory factor, PDS5b, in oral squamous cells carcinomasJournal of Oral Pathology & Medicine, 2016
- Trends in colorectal cancer mortality in Europe: retrospective analysis of the WHO mortality databaseBMJ, 2015
- STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinomaGenome Medicine, 2014
- ERK1/2 Blockade Prevents Epithelial–Mesenchymal Transition in Lung Cancer Cells and Promotes Their Sensitivity to EGFR InhibitionCancer Research, 2014
- STAG2 loss of expression is rare in aneuploid malignant salivary gland neoplasmsJournal of Oral Pathology & Medicine, 2013